Strategies To Address The Challenges Of Outcomes-Based Pricing Agreements For Pharmaceuticals – Health Affairs (blog)


Health Affairs (blog)
Strategies To Address The Challenges Of Outcomes-Based Pricing Agreements For Pharmaceuticals
Health Affairs (blog)
Given major public concern about the costs of pharmaceuticals, there is a particular need to tie reimbursement to value in the drug space. Stakeholders frequently discuss outcomes-based pricing agreements (OBAs) as a promising alternative to

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd